Compare Altria Group Inc (MO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Altria Group Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Altria Group Inc trades at $73.25 (market cap $124.67B), while State Street SPDR S&P Biotech ETF trades at $154.4. The key difference: Altria Group Inc pays a 5.68% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| MO | XBI | |
|---|---|---|
Market Cap | $124.67B | — |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $74.66 | $164.28 |
52-Week Low | $54.72 | $85.16 |
Enterprise Value | $145.75B | — |
Dividend Yield | 5.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Altria Group Inc
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
